Clene Inc.

Contributing Author

Recent Articles by Clene Inc.

Dec-09	Clene to Present at the Emerging Growth Conference CLNN GlobeNewswire
Dec-03	Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8 CLNN GlobeNewswire
Dec-02	Clene to Provide CNM-Au8 ALS Program Update CLNN GlobeNewswire
Nov-20	Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference CLNN GlobeNewswire
Nov-13	Clene Reports Third Quarter 2025 Financial Results and Recent Operating Highlights CLNN GlobeNewswire
Oct-20	Clene to Present at the Emerging Growth Conference CLNN GlobeNewswire
Oct-15	Clene to Participate in a Panel Discussion at the Maxim Growth Summit CLNN GlobeNewswire
Sep-25	Clene Presents New Clinical Data at ECTRIMS 2025 Meeting Demonstrating CNM-Au8 Improves Brain Energy Metabolism in Multiple Sclerosis Patients CLNN GlobeNewswire
Sep-04	Clene Presents Preclinical Data Supporting CNM-Au8 for the Treatment of Parkinson's Disease CLNN GlobeNewswire
Sep-02	Clene to Present at the H.C. Wainwright 27th Annual Global Investment Conference CLNN GlobeNewswire
Aug-14	Clene Reports Second Quarter 2025 Financial Results and Recent Operating Highlights CLNN GlobeNewswire
Aug-13	Clene to Present at the Emerging Growth Conference CLNN GlobeNewswire
Aug-05	Clene to Present at the Canaccord 45th Annual Growth Conference CLNN GlobeNewswire
Jun-30	Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings CLNN GlobeNewswire
May-07	Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights CLNN GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.